Patents Assigned to Albion Laboratories
  • Patent number: 11534458
    Abstract: A nutritional composition comprises (a) one to a plurality of physiologically acceptable calcium salts and/or chelates and (b) one or more phosphorus-containing components, such as phosphate salts, and/or phosphorus-rescuing components, such as phytase. The composition is useful for phosphorus-sparing calcium supplementation of the diet of a human subject, and for treatment of a low bone density condition in a human subject in need thereof.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: December 27, 2022
    Assignee: ALBION LABORATORIES, INC.
    Inventor: Jonathan David Bortz
  • Patent number: 10912796
    Abstract: A nutritional composition comprises (a) one to a plurality of physiologically acceptable calcium salts and/or chelates and (b) one or more phosphorus-containing components, such as phosphate salts, and/or phosphorus-rescuing components, such as phytase. The composition is useful for phosphorus-sparing calcium supplementation of the diet of a human subject, and for treatment of a low bone density condition in a human subject in need thereof.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: February 9, 2021
    Assignee: Albion Laboratories, Inc.
    Inventor: Jonathan David Bortz
  • Patent number: 7946155
    Abstract: Methods are provided for quantitatively determining the amount of unbound metal present in a sample suspected of containing a metal-ligand chelate.
    Type: Grant
    Filed: July 29, 2008
    Date of Patent: May 24, 2011
    Assignee: Albion Laboratories, Inc.
    Inventors: Jennifer W. Hartle, R. Charles Thompson
  • Patent number: 7776842
    Abstract: The present invention includes amino sugar chelates and methods for preparing amino sugar chelates of the formula given below, where M is a metal; R2 and R3 are independently selected from H, OH and hydroxyl substituted C1-C8 alkyl; R4 is selected from H, CO2H, OH, and hydroxyl substituted C1-C8 alkyl; each R5 is independently selected from H, OH, and hydroxyl substituted C1-C8 alkyl; A is selected from CH and O; a is from 0-6; b is from 0-6; n is from 1 to 8. The amino sugar chelates may include matrix stabilizing salts. The compounds and compositions disclosed can be used as nutritional supplements to impart health benefits.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: August 17, 2010
    Assignee: Albion Laboratories, Inc.
    Inventors: Clayton Ericson, DeWayne Ashmead, Stephen D. Ashmead, Amanda Rees
  • Patent number: 7582418
    Abstract: Methods useful for inhibiting growth of a variety of microbes including bacteria and fungi are disclosed. The methods involve contacting a microbe with an inhibitory amount of a zinc chelate. Methods useful for preserving a consumable product are also disclosed.
    Type: Grant
    Filed: November 3, 2005
    Date of Patent: September 1, 2009
    Assignee: Albion Laboratories, Inc.
    Inventor: Robert Charles Thompson
  • Publication number: 20090071232
    Abstract: Methods are provided for quantitatively determining the amount of unbound metal present in a sample suspected of containing a metal-ligand chelate.
    Type: Application
    Filed: July 29, 2008
    Publication date: March 19, 2009
    Applicant: Albion Laboratories, Inc.
    Inventors: Jennifer W. Hartle, R. Charles Thompson
  • Publication number: 20080248583
    Abstract: The present invention is directed to a method of assaying for the presence or absence of a metal-ligand chelate in a sample containing either a metal-ligand chelate or a free ligand. The method includes (a) reacting the sample with a luminophore to obtain either a metal-ligand-luminophore chelate and/or a ligand-luminophore adduct; (b) detecting the electromagnetic spectrum of the reaction product; (c) matching the electromagnetic spectrum of the reaction product with an electromagnetic spectrum metal-ligand chelate luminophore chelate or the electromagnetic spectrum of a ligandluminophore adduct; (d) correlating a match of the electromagnetic spectrum of the reaction product and the electromagnetic spectrum of the metalligand-luminophore chelate with the presence of a metal-ligand chelate, or correlating a match of the electromagnetic spectrum of the reaction product and the electromagnetic spectrum of the ligand-luminophore adduct with the absence of a metal-ligand chelate.
    Type: Application
    Filed: September 16, 2005
    Publication date: October 9, 2008
    Applicant: ALBION LABORATORIES, INC.
    Inventors: Clayton Ericson, Stephen Ashmead
  • Publication number: 20070049553
    Abstract: The present invention includes amino sugar chelates and methods for preparing amino sugar chelates of the formula given below, where M is a metal; R2 and R3 are independently selected from H, OH and hydroxyl substituted C1-C8 alkyl; R4 is selected from H, CO2H, OH, and hydroxyl substituted C1-C8 alkyl; each R5 is independently selected from H, OH, and hydroxyl substituted C1-C8 alkyl; A is selected from CH and O; a is from 0-6; b is from 0-6; n is from 1 to 8. The amino sugar chelates may include matrix stabilizing salts. The compounds and compositions disclosed can be used as nutritional supplements to impart health benefits.
    Type: Application
    Filed: August 23, 2006
    Publication date: March 1, 2007
    Applicant: Albion Laboratories, Inc.
    Inventors: Clayton Ericson, DeWayne Ashmead, Stephen Ashmead, Amanda Rees
  • Patent number: 6114379
    Abstract: A chelate comprised of creatine bonded to an essential mineral selected from the group consisting of Mg, Ca, Cu, Zn, Fe, Cr, Co, Mo, Se and Mn to form a heterocyclic ring. Preferably, the metal is Mg, but Ca, Zn, Fe, Cr and Mn are also preferred. The creatine chelates of the present invention are capable of being absorbed in the stomach or intestines via active transport without substantial metabolism of the chelate. In other words, the creatine ligand is protected by the metal from undergoing cyclization in the acidic environment of the stomach and the metal is made more bioavailable due to the presence of the creatine ligand.
    Type: Grant
    Filed: July 7, 1999
    Date of Patent: September 5, 2000
    Assignee: Albion Laboratories, Inc.
    Inventors: David C. Wheelwright, Stephen D. Ashmead
  • Patent number: 5882685
    Abstract: A method for facilitating digestion of carbohydrates into simple sugars in warm-blooded animals by maintaining and enhancing the natural disaccharidase enzymatic activity in the mucosal cells of the small intestines. Iron is an essential mineral and other minerals selected from the group consisting of copper, zinc, manganese and cobalt are provided in the form of amino acid chelates having a ligand to mineral molar ratio of at least 1:1, a molecular weight of no more than 1500 daltons and a stability constant of between about 10.sup.6 and 10.sup.16 and administered orally. Additionally, magnesium and chromium, as amino acid chelates, may be added to improve disaccharidase activity as may potassium in inorganic salt form or as a 1:1 ligand to potassium amino acid complex. The minerals are taken into the mucosal cells lining the small intestine where they are utilized to facilitate the production and activity of disaccharidase enzymes such as maltases, sucrase and lactase.
    Type: Grant
    Filed: January 22, 1992
    Date of Patent: March 16, 1999
    Assignee: Albion Laboratories, Inc.
    Inventor: H. DeWayne Ashmead
  • Patent number: 5614553
    Abstract: A method for alleviating stress and/or stress related symptoms in humans and other warm-blooded animals particularly when such symptoms are complicated by intestinal malabsorption of minerals is disclosed. Chromium and, optionally, one or more other minerals selected from the group consisting of copper, zinc, manganese, iron and selenium are provided in the form of amino acid chelates having a ligand to mineral ratio of at least 1:1, a molecular weight of no more than 1500 and a stability constant of between about 10.sup.6 and 10.sup.16 and administered orally. They are absorbed from a portion of the intestinal tract other than that utilized for the absorption of cations. The method is particularly adapted to reducing and/or controlling levels of serum cortisol in humans or other animals. The presence of symptoms of stress may first be confirmed or the compositions may be administered as a prophylactic.
    Type: Grant
    Filed: February 21, 1992
    Date of Patent: March 25, 1997
    Assignee: Albion Laboratories, Inc.
    Inventors: H. DeWayne Ashmead, Harvey H. Ashmead, Robert B. Jeppsen
  • Patent number: 4599152
    Abstract: Pure amino acid chelates and a method of their production are disclosed. The amino acid chelates are free of contaminating inorganic anions. The chelate consists of a metal ion comprising iron, zinc, manganese, magnesium, copper, calcium and mixtures thereof. The metal ion is chelated to one or more ligands comprising alpha amino acids, protein hydrolysates, polypeptides, dipeptides, and combinations thereof. A novel process is disclosed wherein the amino acid ligand is brought into reactive contact with a divalent metal ion in an environment which is completely anion free but otherwise conducive to the interaction between the amino acid ligand and the metal ion, with the formation of an amino acid chelate in pure form or, at least, which can readily be recovered from the reactive environment in pure form.
    Type: Grant
    Filed: May 24, 1985
    Date of Patent: July 8, 1986
    Assignee: Albion Laboratories
    Inventor: Harvey H. Ashmead
  • Patent number: 4167564
    Abstract: A method for improving the stability of amino acid-metal complexes or chelates and enhancing the uptake of these complexes into biological tissues. This method comprises forming the metal complexes with amino acids or hydrolyzed proteins and incorporating into them a buffer system which controls the pH of the complex and its surrounding media. This uptake is accomplished by the system of amino acid active transport into the blood stream from which the complex is then carried throughout the entire body.
    Type: Grant
    Filed: September 23, 1974
    Date of Patent: September 11, 1979
    Assignee: Albion Laboratories, Inc.
    Inventor: Ned L. Jensen
  • Patent number: 3969540
    Abstract: A method of preparing metal proteinates from natural proteinacous material without destroying naturally occurring vitamins and hormones which comprises neutralizing a protein containing material, subjecting said material to enzymatic hydrolysis, adjusting the enzymatically digested hydrolysate to a slightly basic pH and adding a metal salt thereto to form a metal proteinate precipitate. The proteinate thus formed is a chelate of polypeptides with metals and is substantially free from metal salts and single amino acid proteinates.
    Type: Grant
    Filed: September 11, 1975
    Date of Patent: July 13, 1976
    Assignee: Albion Laboratories, Inc.
    Inventor: Ned L. Jensen